Blog
GE Just Made Its Biggest Acquisition in Years
Not too long ago, General Electric (NYSE: GE) had a penchant for making big acquisitions. But the storied conglomerate fell on hard times a few years back as profit and cash flow from its power
3 Unstoppable Investments Everyone Needs in Their Portfolio
When most investors are looking for new stocks to buy, they consider things like their risk tolerance, preferred holding periods, and the ultimate timeframe for reaching their goals. Since every
They Own Hundreds of Stocks Between Them. But Here's Why These Investors Say "Don't Sell."
Investors who pick individual stocks want to beat the market. Otherwise, they could just buy a fund that tracks the performance of the market and be done. However, more than beating the market
Why ExxonMobil's Shift to Clean Energy Should Pique ESG Investors' Interest
Dividend collectors and low-valuation fanatics adore ExxonMobil (NYSE: XOM), a go-to holding of safety-minded investors for generations. Yet today's sustainability-minded investors might not be too
3 Electric Vehicle Stocks to Buy and Hold for the Next Decade
The global electric car market grew 43% in 2020 in terms of units, with new car sales soaring 70% in a year when sales of conventional cars dropped, according to the International Energy Agency
DraftKings $20 Billion Acquisition Offer Could Get Complicated
The online gambling market in the U.S. has exploded over the past two years as states have opened up online betting and dozens of companies have joined the market. DraftKings (NASDAQ: DKNG) is
Why U.S. Gunmakers Could Soon Face New Competition
Major names in the U.S. firearms industry, including Smith & Wesson Brands (NASDAQ: SWBI) and Sturm, Ruger & Company (NYSE: RGR) could soon have significant new competition. Czech gun manufacturer
3 High-Yield Dividend Stocks I'd Buy Right Now
It's getting more challenging for income-focused investors to find good stocks with decent yields in the current environment. The average dividend yield on the S&P 500 is down to around 1.3% due to
Should You Buy This Beaten-Down Growth Stock Before Earnings?
Investor sentiment has turned against Micron Technology (NASDAQ: MU) over the past few months because of concerns that memory chip prices might soften based on a slowdown in demand and an increase
This Dividend Aristocrat Has a Partial Fix for Labor-Starved Restaurants
The world is still working out how to live with the coronavirus, and one of the bigger problems has turned out to be labor shortages. For a service industry like restaurants, that's a huge issue.
The Smartest Dividend Aristocrats to Buy With $500 Right Now
High yields can be alluring, but dividend growth stocks are where the real money is to be made. Such stocks increase dividends from time to time, which when reinvested, can grow your initial
Why Starbucks Still Has a Long Growth Runway in Asia
Few American consumer brands have developed the kind of following that Starbucks (NASDAQ: SBUX) has in China. The coffee giant is opening 500 stores a year in China and is expanding in other markets
Can Airbnb Live Up to Investors' High Expectations?
One of the biggest initial public offerings (IPOs) from the last year was Airbnb (NASDAQ: ABNB). The well-known Silicon Valley darling went public in Dec. 2020 and saw its stock soar in the first
Why Is Everyone Talking About Salesforce Stock?
Salesforce.com's (NYSE: CRM) stock price jumped 7% to an all-time high on Sept. 23 after the cloud services giant boosted its revenue forecast for the current fiscal year and initiated its guidance
3 Smart Cannabis Stocks to Buy While They're Cheap
Wall Street's initial post-election excitement over the potential for federal legalization of marijuana has long since worn off. These days, investors are largely back to looking at the business
3 Top Artificial Intelligence Stocks to Buy in September
Artificial intelligence has become an integral part of many technology applications and software, from what online ads shoppers see to how spam gets filtered out of our email inboxes.
But some
Is Buy Now, Pay Later a Good Business to Invest In?
To put it mildly, the buy now, pay later, or BNPL, business is extremely hot right now. But is it a good business to invest in, or should investors largely avoid it? In this Fool Live video clip
Now's the Time to Buy These 3 Stocks
The past three weeks have been volatile ones for the broad market, and they've been downright terrible for Nielsen Holdings (NYSE: NLSN), T-Mobile (NASDAQ: TMUS), and Discovery (NASDAQ: DISC.A)
3 Growth Levers Lululemon Is Pulling Right Now
In the first half of 2021, fitness-apparel company Lululemon Athletica (NASDAQ: LULU) grew its sales an impressive 61% over the same period of two years ago. With this kind of business performance
1 International IPO to Watch in 2022 and Beyond
When it comes to e-commerce, every U.S. investor knows who Amazon is, but South Korea-based Coupang (NYSE: CPNG) could be like investing in the e-commerce giant at a somewhat earlier stage. In this
1 Recession-Resistant Infrastructure Stock to Watch
With a massive amount of infrastructure spending on the horizon, railroads like Union Pacific (NYSE: UNP) could be big winners, and could also help protect your portfolio if a recession hits. In
Disney+ Just Hit 2 Big Roadblocks
At first, it seemed like Disney (NYSE: DIS) could do no wrong when it came to its Disney+ streaming video offering. The service attracted more than 10 million subscribers by the end of its first day
Medicare Open Enrollment Is Coming, so Prepare to Make These 3 Moves
While many of us are eagerly awaiting the return of colored leaves and a full-fledged pumpkin spice takeover, seniors on Medicare may be eagerly awaiting the beginning of open enrollment. Each fall
Snap Up These 3 Chinese Stocks Before the Next Evergrande-Inspired Sell-off
This week, China Evergrande Group (OTC: EGRN.F) became a household name for investors -- and not in a good way. The Chinese real estate giant set off a market panic on Monday on talk that a
2 Best Biotech Stocks to Buy Right Now
Biotech stocks have been on a wild ride in 2021. Thanks to a spate of surprise rejections by the Food and Drug Administration, an increasingly politicized regulatory landscape for COVID-19 vaccines


